e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can different approaches to anti-inflammatory therapy result in different outcomes in cystic fibrosis patients?
A. Pukhalsky, G. Shmarina, D. Pukhalskaya, L. Perederko, N. Kashirskaya, N. Kapranov (Moscow, Russian Federation)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
345
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Pukhalsky, G. Shmarina, D. Pukhalskaya, L. Perederko, N. Kashirskaya, N. Kapranov (Moscow, Russian Federation). Can different approaches to anti-inflammatory therapy result in different outcomes in cystic fibrosis patients?. Eur Respir J 2007; 30: Suppl. 51, 345
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Whether low frequency of hepatobiliary abnormalities in cystic fibrosis patients is associated with anti-inflammatory treatment?
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Do different combinations of bronchodilator therapies have different effects on health status in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003
Results of antifibrotic drugs in the treatment of idiopathic pulmonary fibrosis. A real life study.
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Efficacy of switching antifibrotic therapy in idiopathic pulmonary fibrosis: real life data
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis?
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019
The role of inhaled antibiotics in bronchial infection
Source: Eur Respir Monogr 2013; 60: 120-126
Year: 2013
Are invasive physiological measures necessary for an optimal setting of pressure support in young patients with cystic fibrosis?
Source: Annual Congress 2003 - Physiology of NIV: understanding the effects and chosing the best settings
Year: 2003
Health-economic aspects of cystic fibrosis screening and therapy
Source: Eur Respir Monogr 2014; 64: 304-319
Year: 2014
Do patients with cystic fibrosis participating in clinical trials demonstrate placebo response ? A meta-analysis.
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
What influences patient choice of antifibrotic treatment in IPF?
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020
Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes
Source: Eur Respir J 2013; 42: 1156-1157
Year: 2013
Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes
Source: Eur Respir J 2013; 42: 1155
Year: 2013
Clinical efficacy data for new diagnostic tool for the selection of the most effective antibiotics for patients with cystic fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
Source: ERJ Open Res, 5 (1) 00252-2018; 10.1183/23120541.00252-2018
Year: 2019
Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Clinical response to elexacaftor/tezacaftor/ivacaftor for cystic fibrosis patients in a compassionate use setting
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept